Quantcast

Latest Cervarix Stories

2009-10-15 14:20:10

Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women found that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections. The study, conducted by University of Illinois at Chicago and University of Chicago researchers, appears online and in the November issue of the Journal of Adolescent Health. The findings are reassuring in that girls and young women...

2009-10-09 13:40:19

Cervical cancer prevention efforts should prioritize vaccinating pre-adolescent girls and continued cervical cancer screening Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer. Current guidelines prioritize HPV vaccination of pre-adolescent girls, which has been shown to be cost-effective in previous studies, but the value of vaccinating boys in the United States has been unclear. In a new study,...

c7298a597edbc91e0adeae2a8bd841c21
2009-09-29 13:25:29

Health authorities are working alongside British drug giant GlaxoSmithKline in an effort to investigate the death of a schoolgirl following a cervical cancer vaccination, AFP reported. Following an adverse reaction to the Cervarix vaccine, the 14-year-old girl died on Monday after participating in a national vaccination program that is being carried out in England to protect women against the disease. Health authorities have since isolated the batch of vaccine used in the school. The Cervarix...

2009-09-29 10:57:24

A 14-year-old girl British girl died and several others were hospitalized after being vaccinated against the human papilloma virus, officials said. Natalie Morton died Monday after being vaccinated with Cervarix at her school in Coventry, The Times of London reported Tuesday. Several classmates were hospitalized the same day with side effects from Cervarix, a vaccine that protects against cervical cancer, The Times reported. Morton's is the first death in a national campaign that has...

34365a69a790bfa30540273ccc76cc661
2009-09-18 12:46:41

A federal report released Thursday showed that one in three teenage girls have gotten a cervical cancer vaccine, but vaccination rates vary dramatically between states, The Associated Press reported. It showed that over half of girls ages 13 through 17 in Rhode Island, New Hampshire and Massachusetts got at least one dose of the three-shot vaccination. Mississippi, Georgia and South Carolina -- with fewer than 20 percent who got at least one shot -- were among the stated with the lowest rates...

2009-09-14 01:01:51

U.S. officials say they're considering approving male use of the HPV vaccine that females have been taking since 2006. The Food and Drug Administration advisory committee has recommended males 9 to 26 get Gardasil, a vaccine against the human papillomavirus, a sexually transmitted disease that can cause genital warts and cervical cancer, the Salt Lake Tribune reported. The FDA is expected to decide on the recommendation by year's end. The vaccine was first used for girls and young women in...

2009-09-11 14:25:00

WINSTON-SALEM, N.C., Sept. 11 /PRNewswire-USNewswire/ -- Sales of Merck's HPV vaccine, Gardasil, declined by a third this year, and three years after the FDA approved the drug an estimated three out of four women remain unvaccinated -- despite millions spent on advertising and lobbying for government mandates. A recent marketing study offers a reason. Michelle Steward, assistant professor of marketing at Wake Forest University, and several colleagues conducted an experiment with women,...

84b3ad08b84a2dac80735f899158bd141
2009-09-10 11:05:00

Cervical cancer vaccines have gotten quite a boost since a United States advisory panel recommended the approval of GlaxoSmithKline's Cervarix, which is expected to give Merck & Co's Gardasil a run for its money. According to an overwhelmingly favorable vote by the FDA's panel of vaccine experts on Wednesday, Cervarix appears safe and effective for females ranging in ages from 10 to 25. If the FDA follow the group's recommendations, Glaxo would engage in an intense competition against...

2009-09-10 07:46:00

NEW YORK, Sept. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. World Cancer Therapies Market http://www.reportlinker.com/p0109886/World-Cancer-Therapies-Market.html This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forecasts for the global market is provided for the period of 2006...

2009-09-09 14:53:00

PHILADELPHIA, Sept. 9 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that clinical data support both the efficacy and safety of CERVARIX((R)), the company's candidate cervical cancer vaccine (12-1 and 11-1, respectively). CERVARIX was shown to be highly effective and well tolerated in girls and young women for the prevention of cervical...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related